Determination and pharmacokinetics of acyclovir after ingestion of suspension form.
The study describes, simple, precise, sensitive and accurate HPLC assay with spectrofluorimetric detection for the determination of acyclovir in human plasma. The method was linear over a range 25 1200 ng ml(-1). The average yield in this method exceeded 80%. Limits of quantitation and detection were 25 and 10 ng ml(-1), respectively. On the basis of reported method, a single-dose of pharmacokinetics on 24 men, in two doses (200 and 400 mg) of acyclovir suspension has been investigated. Pharmacokinetic parameters obtained from both doses of the drug were compared. The linearity of acyclovir pharmacokinetics in the investigated dose ranges has been confirmed.
Jankowski
A
A
Medical Center of Postgraduate Education, Department of Biopharmaceutics, Bydgoszcz, Poland.
Jankowska
A L
AL
Lamparczyk
H
H
D000212:Acyclovir / Q000493:pharmacokinetics*; D000284:Administration, Oral; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D002851:Chromatography, High Pressure Liquid; D004305:Dose-Response Relationship, Drug; D005470:Fluorometry; D006801:Humans; D008297:Male; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013535:Suspensions / Q000493:pharmacokinetics*; D013607:Tablets / Q000493:pharmacokinetics*
D013535:Suspensions; D013607:Tablets; D000212:Acyclovir